Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2019, Vol. 33 ›› Issue (3): 9-13.doi: 10.6040/j.issn.1673-3770.1.2018.043

• Invited Review • Previous Articles     Next Articles

Endotypes and precision medicine in chronic sinusitis treatment

Huabin LI(),Yuting LAI,Wenxiu JIANG   

  1. Department of Otolaryngology, Eye and ENT Hospital, Fudan University, Shanghai 200031, China
  • Received:2018-12-03 Revised:2019-04-11 Online:2019-05-20 Published:2019-08-07
  • Contact: Huabin LI E-mail:noseli@163.com

Abstract:

Chronic rhinosinusitis (CRS) is a common otolaryngologic disease, with a complex intrinsic pathological mechanism. Traditional medicine and surgery do not fully treat CRS. In recent years, precision medicine has been used to develop new biological agents to treat CRS based on its phenotype. This article reviews the current endotypes of CRS that have therapeutic significance, including type II inflammatory, eosinophilic, epithelial barrier function, and epithelium-derived cytokine endotypes, and those that are still in the theoretical stage of research, including the non-type II inflammatory phenotype and tissue remodeling.

Key words: Chronic rhinosinusitis, Pathogenesis, Endotype, Precision medicine, Biologic products

CLC Number: 

  • R765.41
1 FokkensWJ, LundVJ, MullolJ, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists[J]. Rhin, 2012, 50(1): 1-12. doi:10.4193/rhino50e2.
doi: 10.4193/rhino50e2
2 KucuksezerUC, OzdemirC, AkdisM, et al. Chronic rhinosinusitis: pathogenesis, therapy options, and more[J]. Expert Opinion on Pharmacotherapy, 2018, 19(16): 1805-1815. doi:10.1080/14656566.2018.1527904.
doi: 10.1080/14656566.2018.1527904
3 TomassenP, VandeplasG, van ZeleT, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers[J]. Journal of Allergy and Clinical Immunology, 2016, 137(5): 1449-1456.e4. doi:10.1016/j.jaci.2015.12.1324.
doi: 10.1016/j.jaci.2015.12.1324
4 CollinsFS, VarmusH. A new initiative on precision medicine[J]. N Engl J Med, 2015, 372(9): 793-795. doi:10.1056/nejmp1500523.
doi: 10.1056/nejmp1500523
5 BachertC, ZhangN, HellingsPW, et al. Endotype-driven care pathways in patients with chronic rhinosinusitis[J]. Journal of Allergy and Clinical Immunology, 2018, 141(5): 1543-1551. doi:10.1016/j.jaci.2018.03.004.
doi: 10.1016/j.jaci.2018.03.004
6 MorrisseyDK, BassiouniA, PsaltisAJ, et al. Outcomes of modified endoscopic Lothrop in aspirin-exacerbated respiratory disease with nasal polyposis[J]. Int Forum Allergy Rhinol, 2016, 6(8): 820-825. doi:10.1002/alr.21739.
doi: 10.1002/alr.21739
7 TurnerJH, ChandraRK, LiP, et al. Identification of clinically relevant chronic rhinosinusitis endotypes using cluster analysis of mucus cytokines[J]. Journal of Allergy and Clinical Immunology, 2018, 141(5): 1895-1897.e7. doi:10.1016/j.jaci.2018.02.002.
doi: 10.1016/j.jaci.2018.02.002
8 BachertC, MannentL, NaclerioRM, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis[J]. JAMA, 2016, 315(5): 469. doi:10.1001/jama.2015.19330.
doi: 10.1001/jama.2015.19330
9 BachertC, ZhangL, GevaertP. Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis[J]. Journal of Allergy and Clinical Immunology, 2015, 136(6): 1431-1440. doi:10.1016/j.jaci. 2015.10.010.
doi: 10.1016/j.jaci. 2015.10.010
10 PettipherR, HunterMG, PerkinsCM, et al. Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459[J]. Allergy, 2014, 69(9): 1223-1232. doi:10.1111/all.12451.
doi: 10.1111/all.12451
11 BachertC, ZhangN, HoltappelsG, et al. Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma[J]. Journal of Allergy and Clinical Immunology, 2010, 126(5): 962-968.e6. doi:10.1016/j.jaci.2010.07.007.
doi: 10.1016/j.jaci.2010.07.007
12 HeckS, NguyenJ, LeDD, et al. Pharmacological therapy of bronchial asthma: the role of biologicals[J]. Int Arch Allergy Immunol, 2015, 168(4): 241-252. doi:10.1159/000443930.
doi: 10.1159/000443930
13 WangXD, ZhangN, BoMY, et al. Diversity of T H cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania[J]. Journal of Allergy and Clinical Immunology, 2016, 138(5): 1344-1353. doi:10.1016/j.jaci.2016.05.041.
doi: 10.1016/j.jaci.2016.05.041
14 KimDW, KimDK, JoA, et al. Age-related decline of neutrophilic inflammation is associated with better postoperative prognosis in non-eosinophilic nasal polyps[J]. PLoS One, 2016, 11(2): e0148442. doi:10.1371/journal.pone.0148442.
doi: 10.1371/journal.pone.0148442
15 KimDK, JinHR, EunKM, et al. Non-eosinophilic nasal polyps shows increased epithelial proliferation and localized disease pattern in the early stage[J]. PLoS One, 2015, 10(10): e0139945. doi:10.1371/journal.pone. 0139945.
doi: 10.1371/journal.pone. 0139945
16 ArmJP, BottoliI, SkerjanecA, et al. Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects[J]. Clin Exp Allergy, 2014, 44(11): 1371-1385. doi:10. 1111/cea.12400.
doi: 10. 1111/cea.12400
17 GauvreauGM, HarrisJM, BouletLP, et al. Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production[J]. Science Translational Medicine, 2014, 6(243): 243ra85. doi:10.1126/scitranslmed.3008961.
doi: 10.1126/scitranslmed.3008961
18 van ZeleT, GevaertP, HoltappelsG, et al. Oral steroids and doxycycline: Two different approaches to treat nasal polyps[J]. Journal of Allergy and Clinical Immunology, 2010, 125(5): 1069-1076.e4. doi:10.1016/j.jaci.2010. 02. 020.
doi: 10.1016/j.jaci.2010. 02. 020
19 SoykaMB, WawrzyniakP, EiweggerT, et al. Defective epithelial barrier in chronic rhinosinusitis: The regulation of tight junctions by IFN-γ and IL-4[J]. Journal of Allergy and Clinical Immunology, 2012, 130(5): 1087-1096.e10. doi:10.1016/j.jaci.2012.05.052.
doi: 10.1016/j.jaci.2012.05.052
20 SteelantB, SeysSF, BoeckxstaensG, et al. Restoring airway epithelial barrier dysfunction: a new therapeutic challenge in allergic airway disease[J]. Rhin, 2017, 54(3): 195-205. doi:10.4193/rhin15.376.
doi: 10.4193/rhin15.376
21 SteelantB, FarréR, WawrzyniakP, et al. Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression[J]. Journal of Allergy and Clinical Immunology, 2016, 137(4): 1043-1053.e5. doi:10.1016/j.jaci.2015.10.050.
doi: 10.1016/j.jaci.2015.10.050
22 GauvreauGM, O'ByrnePM, BouletLP, et al. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses[J]. N Engl J Med, 2014, 370(22): 2102-2110. doi:10.1056/nejmoa1402895.
doi: 10.1056/nejmoa1402895
23 MizutaniN, NabeT, YoshinoS. Interleukin-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodelling in mice[J]. Immunology, 2013, 139(2): 205-218. doi:10.1111/imm.12071.
doi: 10.1111/imm.12071
24 TangW, SmithSG, BeaudinS, et al. IL-25 and IL-25 receptor expression on eosinophils from subjects with allergic asthma[J]. Int Arch Allergy Immunol, 2014, 163(1): 5-10. doi:10.1159/000355331.
doi: 10.1159/000355331
25 LindénA, DahlénB. Interleukin-17 cytokine signalling in patients with asthma[J]. Eur Respir J, 2014, 44(5): 1319-1331. doi:10.1183/09031936.00002314.
doi: 10.1183/09031936.00002314
26 van ZeleT, HoltappelsG, GevaertP, et al. Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps[J]. Am J Rhinol Allergy, 2014, 28(3): 192-198. doi:10.2500/ajra. 2014.28.4033.
doi: 10.2500/ajra. 2014.28.4033
27 LiXY, MengJ, QiaoXM, et al. Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis[J]. Journal of Allergy and Clinical Immunology, 2010, 125(5): 1061-1068. doi:10.1016/j.jaci.2010.02.023.
doi: 10.1016/j.jaci.2010.02.023
28 KimDY, ChoSH, TakabayashiT, et al. Chronic rhinosinusitis and the coagulation system[J]. Allergy Asthma Immunol Res, 2015, 7(5): 421. doi:10.4168/aair.2015.7. 5.421.
doi: 10.4168/aair.2015.7. 5.421
29 TakabayashiT, KatoA, PetersAT, et al. Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression[J]. Am J Respir Crit Care Med, 2013, 187(1): 49-57. doi:10.1164/rccm.201207-1292oc.
doi: 10.1164/rccm.201207-1292oc
30 TakabayashiT, KatoA, PetersAT, et al. Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps[J]. Journal of Allergy and Clinical Immunology, 2013, 132(3): 584-592.e4. doi:10.1016/j.jaci.2013.02.003.
doi: 10.1016/j.jaci.2013.02.003
[1] FENG Sicong, YU Xiaolan, LOU Dan. Evaluation of the effect of Messerklinger middle turbinate plasty on chronic rhinosinusitis with nasal polyps based on the expression of Ki67 and GM-CSF in vesicular tissue [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 31-39.
[2] ZHAI Xuechun, BIAN Xin, CHEN Jingcai, DENG Jiayu, YE Zi, YANG Pingli. Characteristics and influencing factors of anxiety and depression in patients with chronic frontal sinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(2): 35-43.
[3] LIU Yijie, LU Xiuzhen, WU Qiuxin. Research rogress of exosomes in the pathogenesis, diagnosis and treatment in ophthalmic diseases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 135-141.
[4] LI Yangsong, YUAN Fayang, YANG Yan, ZHANG Tian, YU Guodong. Bibliometric analysis of biologic agents for the treatment of chronic rhinosinusitis based on the Web of Science database [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 54-64.
[5] ZHANG Jiaqi, YUAN Ye, HONG Chen, GU Min, CHENG Lei, LU Meiping. Mendelian randomization study of gut microbiota, chronic sinusitis, and nasal polyps: Causal relationships and metabolite-mediated effects [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 49-60.
[6] ZHANG Guangling, CHEN Xingxue, WU Tianyi, SUN Zhanwei, WANG Weiwei, LI Shichao,WANG Guangke. The expression and function of Tespa1 in chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 35-42.
[7] CAO Zhengyong, LI Xiaobo. Comparison of the safety and efficacy of short-course postoperative topical glucocorticoid adjuvant therapy for eCRSwNP combined with asthma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 43-50.
[8] PAN Jiayu, ZHANG Chunlin. Research advances on the etiology and pathogenesis of acute low-frequency sensorineural hearing loss [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 126-131.
[9] WANG Aowei, SHI Wenjie. Study on correlation between traditional Chinese medicine syndrome types and TFH cell related factors in CRSwNP [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 54-60.
[10] ZHANG Jie, NIMA Jizong, XU Xiaodong, ZHOU Jing, LIU Jianmin, LUO Yirui, DU Jintao, BA Luo. Effect of Crocin on Type 2 inflammation in eosinophilic chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 61-67.
[11] WU Wei, WANG Lei, CHEN Sheng, LI Lianyong, WANG Gang. Multidisciplinary research and advances in gastro-oesophageal reflux disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 1-14.
[12] ZHOU Shitong, YANG Yanyan, YANG Yucheng, FANG Hongyan. Pepsin and laryngopharyngeal reflux disease: from pathogenic mechanisms to potential risk factors for pharyngeal and laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 55-60.
[13] LI Ting, ZHAO Chong, WU Xian. The relationship between miR-34a expression in nasal mucosa tissue and postoperative recurrence in patients with chronic sinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 20-25.
[14] SHEN Jiaqi, LI Xiaosa, BI Yanlong, ZHANG Jingfa. The application of artificial intelligence in screening, diagnosis and prognosis of diabetic macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 153-159.
[15] CHEN Xingxue, ZHANG Guangling, WU Tianyi, WANG Weiwei, SUN Zhanwei, LI Shichao, WANG Guangke. Analysis of anti-IL-4Rα monoclonal antibody and endoscopic sinus surgery in the treatment of eosinophilic chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 43-54.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!